MoCRA Talc-Testing Rule Brings Clarity While Raising Target For Class Action Complaints
The FDA’s proposed regulation for talc testing slated for release 29 December will eliminate uncertainty among scientific experts on what is the best method for identifying asbestos but will also give plaintiffs a stationary target for identifying when stakeholders are not in compliance.
You may also be interested in...
The US Food and Drug Administration will delay enforcement of the first registration deadline for cosmetic facility manufacturers and cosmetic product listings under the Modernization of Cosmetics Regulation Act until 1 July, 2024.
‘Junk Litigation Opinions’: J&J’s Talc Liabilities Subsidiary Sues Plaintiff Experts For Disparaging Talcum Powders
What ails J&J in litigation concerning the alleged role of its Johnson’s Baby Powder and other talcum products in plaintiffs’ mesothelioma – ie, “tactics to pollute the scientific literature” – is a growing systemic problem, according to the firm’s wholly owned indirect subsidiary LTL Management.
The J&J company holding the firm’s liabilities relating to talc litigation, which declared bankruptcy in 2021 shortly after its formation, had its Chapter 11 petition denied by the Third Circuit on 30 January. Attorneys weigh in on the implications for J&J and wider industry.